Lynne Hohlfeld
Director of Finance/CFO at Asuragen, Inc.
Profile
Lynne Hohlfeld is currently the CFO & Senior VP-Corporate Development at Asuragen, Inc. She previously worked as a Controller at LifeCell Corp.
from 1997 to 1999, SVP, Chief Operating & Financial Officer at Bacterial Barcodes, Inc. from 2000 to 2004, Vice President-Finance at PharmaFrontiers Corp.
in 2006, Chief Financial Officer & Secretary at Opexa Therapeutics, Inc. from 2006 to 2009, and Chief Financial Officer & Corporate Secretary at Mirna Therapeutics, Inc. She also worked as the Chief Financial Officer & Vice President at Denota Ventures from 2004 to 2006.
Ms. Hohlfeld received her undergraduate degree from the University of Wisconsin.
Lynne Hohlfeld active positions
Companies | Position | Start |
---|---|---|
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Director of Finance/CFO | 2009-07-07 |
Former positions of Lynne Hohlfeld
Companies | Position | End |
---|---|---|
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Director of Finance/CFO | 2009-03-05 |
PharmaFrontiers Corp. | Director of Finance/CFO | 2006-06-18 |
Denota Ventures | Director of Finance/CFO | 2006-03-31 |
Bacterial Barcodes, Inc.
Bacterial Barcodes, Inc. Medical SpecialtiesHealth Technology Bacterial Barcodes, Inc. provides equipment, reagents, and software for microbial genotyping of bacteria and fungi. The company was founded on November 10, 2005 and is headquartered in Durham, NC. | Director of Finance/CFO | 2004-02-29 |
Spectral Genomics, Inc.
Spectral Genomics, Inc. BiotechnologyHealth Technology Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX | Director of Finance/CFO | 2004-02-29 |
Training of Lynne Hohlfeld
University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 8 |
---|---|
LifeCell Corp.
LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
Spectral Genomics, Inc.
Spectral Genomics, Inc. BiotechnologyHealth Technology Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX | Health Technology |
Bacterial Barcodes, Inc.
Bacterial Barcodes, Inc. Medical SpecialtiesHealth Technology Bacterial Barcodes, Inc. provides equipment, reagents, and software for microbial genotyping of bacteria and fungi. The company was founded on November 10, 2005 and is headquartered in Durham, NC. | Health Technology |
PharmaFrontiers Corp. | Health Technology |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Denota Ventures | |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
- Stock Market
- Insiders
- Lynne Hohlfeld